GlassScriptPhysician profile
James M Hammond
NPI 1518232735
$2,000.54
in general payments reported to CMS, 2019-2025
14 companies · $513 in 2025
The $513 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $572 · 2023: $237 · 2024: $296 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $685.13 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Solyx Sis System |
| Abbott Laboratories | $532.60 | 2021-2023 | Proclaim |
| Edwards Lifesciences Corporation | $215.20 | 2022 | |
| Medtronic, INC. | $209.10 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Neurocrine Biosciences, INC. | $118.98 | 2025 | |
| Curonix LLC | $56.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotronik Nro, INC. | $50.96 | 2024 | Prospera |
| Si-Bone, INC. | $24.93 | 2023 | |
| Spinal Simplicity, LLC | $21.33 | 2022 | |
| Mallinckrodt Hospital Products INC. | $20.49 | 2024 | Acthar |
| Nevro Corp. | $18.94 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.23 | 2025 | |
| Lundbeck LLC | $14.32 | 2022 | |
| Vertos Medical, INC. | $13.62 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.